Donaldson does not contract directly with insurance plans. We operate on a fee-for-service model because insurance structures often limit the time, testing and personalized care required to address complex conditions like PCOS at the root cause. This allows you direct access to your care team, comprehensive diagnostic testing and individualized treatment plans without surprise restrictions or coverage-driven compromises.

Many patients are able to use Health Savings Accounts (HSA) or Flexible Spending Accounts (FSA) for qualified services. Financing options are also available, and our team is always happy to discuss the best options for you.

Our Flexible Payment Options

PCOS is one of the most common hormonal conditions affecting women, with research estimating that up to 1 in 10 women of reproductive age meet diagnostic criteria, though many remain undiagnosed. Rather than having a single cause, this condition typically develops from a combination of interconnected factors, including:

• Genetic predisposition
• Insulin resistance and blood sugar dysregulation
• Hormonal signaling imbalances
• Chronic inflammation
• Stress and cortisol dysregulation
• Gut health and microbiome disruption
• Environmental and endocrine-disrupting toxin exposure

PCOS is complex and common. It is not caused by anything you did wrong, nor is it a reflection of your discipline, choices or character.

When appropriate, we use targeted hormone support (including progesterone and anti-androgen strategies) to help regulate cycles and alleviate symptoms using a fully personalized approach.

No. There is technically no cure, but symptoms can often be managed so effectively that PCOS has minimal impact on daily life and long-term health.

Many patients notice changes within a few months, though timelines vary depending on breadth of symptoms, severity of symptoms, dedication to the personalized treatment plan and other underlying contributors or preexisting conditions.

Yes, despite what some online forums may tell you. The focus is on how carbohydrates are consumed (including type, timing and pairing) to support insulin response.

Yes, in some cases. GLP-1 medications have shown promise in improving several concerns that commonly overlap with PCOS, including insulin resistance, weight management, androgen-related symptoms and menstrual cycle regulation. Emerging research suggests these medications may be helpful for patients whose PCOS is strongly influenced by metabolic dysfunction.

That said, GLP-1 medications are not FDA-approved for the treatment of PCOS, and current data is still evolving. Additionally, there is not enough evidence at this time to confidently recommend GLP-1 therapies for patients whose primary PCOS concern is fertility. For this reason, we approach GLP-1 use thoughtfully; it is one potential tool within a comprehensive, individualized treatment plan that may be used.

Unmanaged PCOS is associated with an increased risk of long-term health concerns, including:

• Insulin resistance
• Type 2 diabetes
• Cardiovascular disease
• Metabolic complications

Beyond measurable health risks, untreated PCOS — especially PCOS-related obesity — can continue to impact daily quality of life through persistent fatigue, mood changes, weight challenges and hormone-related symptoms. Proactively addressing PCOS allows many patients to not only reduce future health risks but also improve overall wellbeing and day-to-day function.